Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Clinical Trials

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer

Explore clinical trials studying Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer trial results

Recruiting

Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.

NCT05190094

Conditions: Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
Locations: EHS LCC Blida, Medical Oncology Center Blida, Algeria

University Hospital Sétif, Sétif, Algeria

King Hussein Cancer Center (KHCC) - Amman Amman, Jordan

King Saud Medical City - KSMC Riyadh, Saudi Arabia

View Trial Details